The osteoarthritis therapeutics market in 2024 is set to witness significant growth, driven by rising demand for effective treatments and an increasing prevalence of the disease worldwide. Osteoarthritis, a degenerative joint disease, affects millions of people globally, with symptoms ranging from mild discomfort to severe pain and disability. The market for therapeutics aimed at managing this condition is expanding, reflecting advancements in medical research, growing awareness, and an aging population.